Explore NCX1/SLC8A1 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
In cardiac myocytes, Ca(2+) concentrations alternate between high levels during contraction and low levels during relaxation. The increase in Ca(2+) concentration during contraction is primarily due to release of Ca(2+) from intracellular stores. However, some Ca(2+) also enters the cell through the sarcolemma (plasma membrane). During relaxation, Ca(2+) is sequestered within the intracellular stores. To prevent overloading of intracellular stores, the Ca(2+) that entered across the sarcolemma must be extruded from the cell. The Na(+)-Ca(2+) exchanger is the primary mechanism by which the Ca(2+) is extruded from the cell during relaxation. In the heart, the exchanger may play a key role in digitalis action. The exchanger is the dominant mechanism in returning the cardiac myocyte to its resting state following excitation.[supplied by OMIM, Apr 2004]
| Target ID |
GM-T07775
|
| Target Name |
NCX1/SLC8A1
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
6546
|
| Gene ID |
100034157 (Equus caballus), 20541 (Mus musculus), 29715 (Rattus norvegicus), 337925 (Bos taurus) 475738 (Canis lupus familiaris), 493807 (Felis catus), 574193 (Macaca mulatta), 6546 (Homo sapiens)
|
| Target Alternative Names |
D930008O12Rik,NCX1,Na(+)/Ca(2+)-exchange protein 1,Ncx,Ncx1,SLC8A1,Slc8a1,Sodium/calcium exchanger 1,Solute carrier family 8 member 1
|
| Uniprot Accession |
P70414,Q01728,P48765,P23685,P48767,P32418
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease from KEGG |
Calcium signaling pathway, cGMP-PKG signaling pathway, Adrenergic signaling in cardiomyocytes, Olfactory transduction, Protein digestion and absorption, Mineral absorption, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy
|
| Gene Ensembl |
ENSECAG00000004050, ENSMUSG00000054640, ENSBTAG00000013861, ENSCAFG00845024998, ENSMMUG00000015508, ENSG00000183023
|
Pre-made viral vector of NCX1/SLC8A1 cDNA Clones/ORF Plasmid
NCX1/SLC8A1 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo6546 | Pre-made Human SLC8A1/NCX1 siRNA oligo Duplex | 6546 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo29715 | Pre-made Rat Slc8a1/Ncx/Ncx1 siRNA oligo Duplex | 29715 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo20541 | Pre-made Mouse Slc8a1/Ncx1/D930008O12Rik siRNA oligo Duplex | 20541 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo574193 | Pre-made Cynomolgus/Rhesus macaque SLC8A1/NCX1 siRNA oligo Duplex | 574193 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo493807 | Pre-made Cat/Feline SLC8A1/NCX1 siRNA oligo Duplex | 493807 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo475738 | Pre-made Dog/Canine SLC8A1/NCX1 siRNA oligo Duplex | 475738 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo337925 | Pre-made Bovines/Cattle SLC8A1/NCX1 siRNA oligo Duplex | 337925 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100034157 | Pre-made Equine/Horse SLC8A1 siRNA oligo Duplex | 100034157 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
NCX1/SLC8A1 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T07775-Ab | Human | Anti-Human NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T07775-Ab | Rat | Anti-Rat NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T07775-Ab | Mouse | Anti-Mouse NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T07775-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T07775-Ab | Cat/Feline | Anti-Cat/Feline NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T07775-Ab | Dog/Canine | Anti-Dog/Canine NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T07775-Ab | Bovines/Cattle | Anti-Bovines/Cattle NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T07775-Ab | Equine/Horse | Anti-Equine/Horse NCX1/SLC8A1 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
NCX1/SLC8A1 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T07775-Ag | Human | Human NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T07775-Ag | Rat | Rat NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T07775-Ag | Mouse | Mouse NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T07775-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T07775-Ag | Cat/Feline | Cat/Feline NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T07775-Ag | Dog/Canine | Dog/Canine NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T07775-Ag | Bovines/Cattle | Bovines/Cattle NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T07775-Ag | Equine/Horse | Equine/Horse NCX1/SLC8A1 VLP (virus-like particle) | HEK293 | Products Developing |